+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process

Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process

European Journal of Pharmaceutics and Biopharmaceutics 66(3): 413-421

In the present study, the practically insoluble drug, simvastatin (SV), and its inclusion complex with hydroxypropyl beta-cyclodextrin (HP-beta-CD) prepared using supercritical antisolvent (SAS) process were investigated to improve the aqueous solubility and the dissolution rate of drug, thus enhancing its bioavailability. Inclusion complexation in aqueous solution and solid state was evaluated by the phase solubility diagram, differential scanning calorimetry (DSC), powder X-ray diffractometry (PXRD), Fourier-transform infrared spectroscopy (FT-IR) and scanning electron microscopy (SEM). The phase solubility diagram with HP-beta-CD was classified as A(L)-type at all temperatures investigated, indicating the formation of 1:1 stoichiometric inclusion complex. The apparent complexation constants (K-1:1) calculated from phase solubility diagram were 774, 846 and 924 M-1 at 25, 37 and 45 +/- 0.5 degrees C, respectively. No endothermic and characteristic diffraction peaks corresponding to SV was observed for the inclusion complex in DSC and PXRD. FT-IR study demonstrated the presence of inter-molecular hydrogen bonds between SV and HP-beta-CD in inclusion complex, resulting in the formation of amorphous form. Aqueous solubility and dissolution studies indicated that the dissolution rates were remarkably increased in inclusion complex, compared with the physical mixture and drug alone. Moreover, SV/HP-beta-CD inclusion complex performed better than SV in reducing total cholesterol and triglyceride levels. This could be primarily attributed to the improved solubility and dissolution associated with inclusion complex between drug and HP-beta-CD. In conclusion, SAS process could be a useful method for the preparation of the inclusion complex of drug with HP-beta-CD and its solubility, dissolution rate and hypolipidernic activity were significantly increased by complexation between SV and HP-beta-CD.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 016732951

Download citation: RISBibTeXText

PMID: 17240129

DOI: 10.1016/j.ejpb.2006.11.013

Related references

Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement. International Journal of Pharmaceutics 511(2): 921-930, 2017

Preparation of bitter taste masked cetirizine dihydrochloride/β-cyclodextrin inclusion complex by supercritical antisolvent (SAS) process. Journal of Supercritical Fluids 55(1): 348-357, 2010

Preparation process of rutacarpine-hydroxypropyl-beta-cyclodextrin inclusion complex. Zhongguo Zhong Yao Za Zhi 39(5): 828-832, 2014

Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. preparation and properties of rofecoxib hydroxypropyl beta-cyclodextrin inclusion complex: a technical note. Aaps Pharmscitech 6(1): E83-E90, 2005

Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin. Journal of Biomaterials Applications 17(3): 197-206, 2003

Preparation and characterization of dihydroartemisinin/ hydroxypropyl-beta-cyclodextrin inclusion complex. Yao Xue Xue Bao 47(4): 529-534, 2013

Preparation, characterization, and biotransformation of the inclusion complex of phytosterols and hydroxypropyl-beta-cyclodextrin by Mycobacterium neoaurum. Zeitschrift für Naturforschung. C, Journal of Biosciences 66(5-6): 277-282, 2011

Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Journal of Pharmaceutical and Biomedical Analysis 40(1): 122-127, 2005

Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex. Yao Xue Xue Bao 40(4): 369-372, 2005

Imazalil-cyclomaltoheptaose (beta-cyclodextrin) inclusion complex: preparation by supercritical carbon dioxide and 13C CPMAS and 1H NMR characterization. Carbohydrate Research 338(21): 2227-2232, 2003

Preparation and characterization of the inclusion complex of hypocrellin A with hydroxypropyl-β-cyclodextrin. European Food Research and Technology 231(5): 781-788, 2010

Preparation and properties of valdecoxib-hydroxypropyl beta-cyclodextrin inclusion complex. Pda Journal of Pharmaceutical Science and Technology 61(3): 175-182, 2007

Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin. European Journal of Pharmaceutics and Biopharmaceutics 46(3): 355-360, 1999

Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2-hydroxypropyl)-β-cyclodextrin. Journal of Pharmacy and Pharmacology 70(11): 1485-1493, 2018

Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation. Carbohydrate Polymers 110: 329-337, 2015